Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Is there a 2024 Duloxetine recall? FDA flags 7,100+ bottles of generic Cymbalta antidepressants
A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.
FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemical
The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.
FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why
The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the second-highest risk classification. Over 7,100 bottles of Duloxetine were recalled, including 500 delayed-release 20mg capsules. The lot number is 220128, and the expiration date is 12/2024, per the FDA report.
Thousands of duloxetine bottles, an antidepressant sold as Cymbalta, recalled over toxic chemical
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a toxic chemical.
FDA: Thousands of Bottles of Popular Antidepressant Recalled Over Potentially Cancer-Causing Chemical
Over 7,000 bottles of the antidepressant medication duloxetine, sold under the brand name Cymbalta, have been recalled, the FDA announced. The medication, produced by Towa Pharmaceutical Europe and distributed nationwide,
FDA recalls thousands of antidepressant bottles due to cancer-causing chemical
The Food and Drug Administration (FDA) issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine due to the possible presence of a carcinogen. Duloxetine
Thousands of bottles of popular antidepressant recalled: 3 things to know
Thousands of bottles of a popular antidepressant medication are being recalled due to the presence of what the National Library of Medicine describes as a toxic chemical, according to a notice from the U.S. Food and Drug Administration.
FDA recalls more than 7,000 bottles of antidepressant duloxetine over toxic chemical
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant duloxetine over the presence of a toxic chemical.
FDA recalls over 7,000 bottles of antidepressant duloxetine
The recall was initiated due to the discovery of N-nitroso-duloxetine, a chemical impurity classified as a nitrosamine.
FDA recalls thousands of bottles of antidepressants over toxic chemicals
The Food and Drug Administration (FDA) has recalled over 7,000 bottles of the popular antidepressant duloxetine – sold under the brand name Cymbalta. U
The Milford Daily News
9m
FDA recalls duloxetine, antidepressant known as Cymbalta, over possible cancerous chemical
Here's what to know about the
recall
. The FDA issued a
recall
of about 7,100 bottles of duloxetine, an antidepressant commonly sold under the name
Cymbalta
, earlier this month. The agency said ...
WGAU Athens Radio on MSN
1d
FDA issues Cymbalta recall
More than 7,100 bottles of Cymbalta is being pulled by the FDA after the toxic chemical was discovered. In addition to treat ...
11h
FDA recalls over 7,000 bottles of antidepressant due to possible cancerous chemical
The FDA has recalled thousands of bottles of the antidepressant duloxetine, sold under brand name Cymbalta, due to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
DOJ reaches settlement
DA urges resentencing
Workers reject new contract
4 astronauts return to Earth
Kristy now Category 5
AI firm sued over suicide
USF basketball coach dies
Funeral home owners guilty
US mortgage rate climbs
Grammy-winning singer dies
Hack impacted 100M people
Seeks Jan. 6 case dismissal
New UN climate report
Judge blocks $8.5B deal
MO AG to probe Google
LA Times editor quits
Watchdog cautions firms
Sri Lanka attack alert
Weekly jobless claims fall
Reporter struck by shrapnel
US new home sales rise
Mailbox fire damages ballots
Arbery case retrial motions
Florida sues Garland
NY gun control law ruling
Philly synagogue targeted
Sued over E. coli outbreak
Nigeria releases US exec
Ohio abortion ban blocked
Nevada lithium mine OK’d
Related topics
Duloxetine
Food and Drug Administration
Feedback